公开(公告)号：US08940737B2

公开(公告)日：2015-01-27

申请号：US13649950

申请日：2012-10-11

Applicant: AbbVie Inc.

Inventor： Le Wang ,  George Doherty ,  Xilu Wang ,  Zhi-Fu Tao ,  Milan Bruncko ,  Aaron R. Kunzer ,  Michael D. Wendt ,  Xiaohong Song ,  Robin Frey ,  Todd M. Hansen ,  Gerard M. Sullivan ,  Andrew Judd ,  Andrew Souers

IPC: A61K31/54 ,  A61K45/06 ,  C07D417/14 ,  A61K31/5377 ,  A61K31/4725

CPC classification number: A61K31/4725 ,  A61K31/5377 ,  A61K45/06 ,  C07D417/14 ,  C07D471/04

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-xL protein.

Abstract translation: 公开了抑制抗凋亡Bcl-xL蛋白活性的化合物，含有该化合物的组合物和治疗疾病的方法，其中表达抗凋亡Bcl-xL蛋白。

公开(公告)号：US20140187531A1

公开(公告)日：2014-07-03

申请号：US14195666

申请日：2014-03-03

Applicant: AbbVie Inc.

Inventor： Milan Bruncko ,  Hong Ding ,  Steven W. Elmore ,  Aaron R. Kunzer ,  Christopher L. Lynch ,  William J. McClellan ,  Cheol-Min Park ,  Andrew M. Petros ,  Xiaohong Song ,  Xilu Wang ,  Noah P. Tu ,  Michael D. Wendt ,  Alexander R. Shoemaker ,  Michael J. Mitten

IPC: C07D295/155 ,  C07D209/52 ,  C07D405/12 ,  C07D211/34 ,  C07D491/048 ,  C07D451/02 ,  C07D233/22 ,  C07D207/08 ,  C07D205/04

CPC classification number: C07D295/155 ,  C07C311/51 ,  C07D205/04 ,  C07D207/06 ,  C07D207/08 ,  C07D207/09 ,  C07D207/12 ,  C07D207/14 ,  C07D207/16 ,  C07D207/20 ,  C07D207/24 ,  C07D207/50 ,  C07D209/02 ,  C07D209/52 ,  C07D211/14 ,  C07D211/20 ,  C07D211/26 ,  C07D211/34 ,  C07D211/38 ,  C07D211/42 ,  C07D211/46 ,  C07D211/48 ,  C07D211/58 ,  C07D211/62 ,  C07D211/70 ,  C07D211/72 ,  C07D213/36 ,  C07D213/38 ,  C07D213/42 ,  C07D213/70 ,  C07D213/74 ,  C07D213/81 ,  C07D213/82 ,  C07D215/12 ,  C07D231/12 ,  C07D231/56 ,  C07D233/06 ,  C07D233/22 ,  C07D233/24 ,  C07D233/61 ,  C07D233/64 ,  C07D235/08 ,  C07D239/06 ,  C07D239/20 ,  C07D239/38 ,  C07D241/04 ,  C07D249/18 ,  C07D257/04 ,  C07D261/20 ,  C07D263/12 ,  C07D263/22 ,  C07D263/58 ,  C07D265/30 ,  C07D267/10 ,  C07D273/01 ,  C07D277/04 ,  C07D277/36 ,  C07D277/74 ,  C07D295/185 ,  C07D295/30 ,  C07D307/14 ,  C07D307/22 ,  C07D307/81 ,  C07D309/14 ,  C07D309/20 ,  C07D317/66 ,  C07D333/20 ,  C07D333/34 ,  C07D335/02 ,  C07D401/10 ,  C07D401/12 ,  C07D403/04 ,  C07D403/12 ,  C07D405/12 ,  C07D409/10 ,  C07D413/04 ,  C07D451/02 ,  C07D471/08 ,  C07D487/04 ,  C07D487/08 ,  C07D491/04 ,  C07D491/048 ,  C07D491/08 ,  C07D498/08

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic protein family members, compositions containing the compounds and uses of the compounds for preparing medicaments for treating diseases during which occurs expression one or more than one of an anti-apoptotic protein family member.

Abstract translation: 公开了抑制抗凋亡蛋白家族成员的活性的化合物，含有化合物的组合物和该化合物用于制备用于治疗疾病的药物的用途，其中发生表达一种或多种抗凋亡蛋白家族成员。

公开(公告)号：US20140107119A1

公开(公告)日：2014-04-17

申请号：US14081940

申请日：2013-11-15

Applicant: AbbVie Inc.

Inventor： Milan Bruncko ,  Hong Ding ,  George A. Doherty ,  Steven W. Elmore ,  Lisa Hasvold ,  Laura A. Hexamer ,  Aaron R. Kunzer ,  Robert A. Mantei ,  William J. McClellan ,  Chang H. Park ,  Cheol-Min Park ,  Andrew M. Petros ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-fu Tao ,  Gary T. Wang ,  Le Wang ,  Xilu Wang ,  Michael D. Wendt ,  Todd M. Hansen

IPC: A61K31/5377 ,  A61K31/496 ,  C07D295/155 ,  A61K45/06 ,  C07D215/14 ,  C07D405/12 ,  C07D209/20 ,  C07D309/32 ,  C07D231/56

CPC classification number: C07D215/14 ,  A61K31/496 ,  A61K31/5377 ,  A61K45/06 ,  C07D209/20 ,  C07D209/32 ,  C07D211/96 ,  C07D213/64 ,  C07D215/20 ,  C07D217/16 ,  C07D231/56 ,  C07D235/26 ,  C07D249/04 ,  C07D295/125 ,  C07D295/13 ,  C07D295/14 ,  C07D295/155 ,  C07D309/08 ,  C07D309/14 ,  C07D309/32 ,  C07D401/12 ,  C07D405/12 ,  C07D417/12 ,  C07D487/04

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.

公开(公告)号：US20140057889A1

公开(公告)日：2014-02-27

申请号：US14058159

申请日：2013-10-18

Applicant: AbbVie Inc.

Inventor： Milan Bruncko ,  Hong Ding ,  George A. Doherty ,  Steven W. Elmore ,  Lisa Hasvold ,  Laura A. Hexamer ,  Aaron R. Kunzer ,  Robert A. Mantei ,  William J. McClellan ,  Chang H. Park ,  Cheol-Min Park ,  Andrew M. Petros ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Gary T. Wang ,  Le Wang ,  Xilu Wang ,  Michael D. Wendt

IPC: A61K31/5377 ,  A61K31/496 ,  C07D413/06 ,  C07D401/06 ,  A61K45/06 ,  A61K31/407 ,  C07D403/06 ,  A61K31/501 ,  C07D241/04 ,  A61K31/495 ,  C07D405/06 ,  C07D487/04

CPC classification number: C07D401/12 ,  A61K31/407 ,  A61K31/495 ,  A61K31/496 ,  A61K31/501 ,  A61K31/5377 ,  A61K45/06 ,  C07D209/08 ,  C07D209/32 ,  C07D211/58 ,  C07D211/96 ,  C07D213/64 ,  C07D215/20 ,  C07D217/16 ,  C07D231/56 ,  C07D235/26 ,  C07D241/04 ,  C07D249/04 ,  C07D295/125 ,  C07D295/14 ,  C07D295/155 ,  C07D309/04 ,  C07D309/14 ,  C07D401/06 ,  C07D403/06 ,  C07D405/06 ,  C07D405/12 ,  C07D405/14 ,  C07D413/06 ,  C07D417/12 ,  C07D471/04 ,  C07D487/04

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 or Bcl-xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti-apoptotic Bcl-2 protein.

Abstract translation: 公开了抑制抗凋亡Bcl-2或Bcl-xL蛋白活性的化合物，含有化合物的组合物和治疗疾病的方法，其中表达有抗凋亡Bcl-2蛋白。

公开(公告)号：US20130096121A1

公开(公告)日：2013-04-18

申请号：US13649950

申请日：2012-10-11

Applicant: AbbVie Inc.

Inventor： Le Wang ,  George Doherty ,  Xilu Wang ,  Zhi-Fu Tao ,  Milan Bruncko ,  Aaron R. Kunzer ,  Michael D. Wendt ,  Xiaohong Song ,  Robin Frey ,  Todd M. Hansen ,  Gerard M. Sullivan ,  Andrew Judd ,  Andrew Souers

IPC: A61K31/4725 ,  A61K31/5377 ,  A61P35/02 ,  C07D417/14 ,  A61P35/00

CPC classification number: A61K31/4725 ,  A61K31/5377 ,  A61K45/06 ,  C07D417/14 ,  C07D471/04

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bc1-xL proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bc1-xL protein.

Abstract translation: 公开了抑制抗凋亡Bc1-xL蛋白活性的化合物，含有该化合物的组合物和治疗疾病的方法，其中表达有抗凋亡Bc1-xL蛋白。

公开(公告)号：US20250019364A1

公开(公告)日：2025-01-16

申请号：US18883472

申请日：2024-09-12

Applicant: AbbVie Inc. ,  Genentech, Inc. ,  The Walter and Eliza Hall Institute of Medical Research

Inventor： Milan Bruncko ,  Hong Ding ,  George A. Doherty ,  Steven W. Elmore ,  Lisa A. Hasvold ,  Laura Hexamer ,  Aaron R. Kunzer ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Gary T. Wang ,  Le Wang ,  Xilu Wang ,  Michael D. Wendt ,  Robert Mantei ,  Todd M. Hansen

IPC: C07D401/12 ,  A61K31/496 ,  C07D209/82 ,  C07D401/14 ,  C07D403/12 ,  C07D471/04 ,  C07D519/00

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

公开(公告)号：US11897864B2

公开(公告)日：2024-02-13

申请号：US17938835

申请日：2022-10-07

Applicant: AbbVie Inc. ,  Genentech, Inc. ,  The Walter and Eliza Hall Institute of Medical Research

Inventor： Milan Bruncko ,  Hong Ding ,  George A. Doherty ,  Steven W. Elmore ,  Lisa A. Hasvold ,  Laura Hexamer ,  Aaron R. Kunzer ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Gary T. Wang ,  Le Wang ,  Xilu Wang ,  Michael D. Wendt ,  Robert Mantei ,  Todd M. Hansen

IPC: C07D401/12 ,  C07D401/14 ,  C07D519/00 ,  C07D471/04 ,  C07D209/82 ,  C07D403/12 ,  A61K31/496

CPC classification number: C07D401/12 ,  A61K31/496 ,  C07D209/82 ,  C07D401/14 ,  C07D403/12 ,  C07D471/04 ,  C07D519/00 ,  Y02A50/30

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

公开(公告)号：US20230143532A1

公开(公告)日：2023-05-11

申请号：US17938835

申请日：2022-10-07

Applicant: AbbVie Inc. ,  Genentech, Inc. ,  The Walter and Eliza Hall Institute of Medical Research

Inventor： Milan Bruncko ,  Hong Ding ,  George A. Doherty ,  Steven W. Elmore ,  Lisa A. Hasvold ,  Laura Hexamer ,  Aaron R. Kunzer ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Gary T. Wang ,  Le Wang ,  Xilu Wang ,  Michael D. Wendt ,  Robert Mantei ,  Todd M. Hansen

IPC: C07D401/12 ,  C07D401/14 ,  C07D519/00 ,  C07D471/04 ,  C07D209/82 ,  C07D403/12 ,  A61K31/496

CPC classification number: C07D401/12 ,  A61K31/496 ,  C07D209/82 ,  C07D401/14 ,  C07D403/12 ,  C07D471/04 ,  C07D519/00 ,  Y02A50/30

Abstract: Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.

公开(公告)号：US20200010480A1

公开(公告)日：2020-01-09

申请号：US16575114

申请日：2019-09-18

Applicant: AbbVie Inc. ,  AbbVie Deutschland GmbH & Co. KG

Inventor： Patrick B. Brady ,  Wilfried Braje ,  Yujia Dai ,  George A. Doherty ,  Jane Gong ,  Katja Jantos ,  Cheng Ji ,  Andrew S. Judd ,  Aaron R. Kunzer ,  Chunqiu Lai ,  Anthony Mastracchio ,  Roberto M. Risi ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Jesse A. Teske ,  Xilu Wang ,  Michael D. Wendt ,  Yiyun Yu ,  Guidong Zhu ,  Thomas D. Penning

IPC: C07D498/18 ,  A61P35/00 ,  C07D519/00 ,  C07D495/18 ,  C07D495/16

Abstract: The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).

公开(公告)号：US20190055264A1

公开(公告)日：2019-02-21

申请号：US15998688

申请日：2018-08-15

Applicant: AbbVie Inc. ,  AbbVie Deutschland GmbH & Co. KG

Inventor： Patrick B. Brady ,  Wilfried Braje ,  Yujia Dai ,  George A. Doherty ,  Jane Gong ,  Katja Jantos ,  Cheng Ji ,  Andrew S. Judd ,  Aaron R. Kunzer ,  Chunqiu Lai ,  Anthony Mastracchio ,  Roberto M. Risi ,  Xiaohong Song ,  Andrew J. Souers ,  Gerard M. Sullivan ,  Zhi-Fu Tao ,  Jesse A. Teske ,  Xilu Wang ,  Michael D. Wendt ,  Yiyun Yu ,  Guidong Zhu ,  Thomas D. Penning

IPC: C07D498/18 ,  C07D495/18 ,  C07D519/00 ,  A61P35/00

Abstract: The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).